LYCOS RETRIEVER 
Wyeth: Cushing
built 787 days ago
Wyeth is an Equal Opportunity Employer and complies with all applicable federal, state, and local laws regarding nondiscrimination. Wyeth provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, or status as a veteran.
Source:
Under PIPEDA, and other applicable privacy legislation, there are limited circumstances where Wyeth may collect, use or disclose personal information without your knowledge and consent. For example, personal information may be collected: where regulations specify that the information is "publicly available" (i.e., telephone directories); for the purpose of responding to an emergency that threatens the life, health or security of an individual; or to comply with a subpoena, warrant or other court order.
Source:
Wyeth could gain up to $5 million through next year in a licensing deal with Novavax covering its virus-like particle technology for use in vaccine development. The technology creates viruses that mimic the disease-causing virus but lacks genetic material needed to make it a threat. Release
Source:
There is little in the biography of John Wyeth (1770-1858)[3] to suggest that his interest in psalmody was any more than that of an amateur. As a boy in Cambridge, Massachusetts, he may have attended a singing-school during the 1780s, an important decade in the growth of native psalmody. As a printer’s apprentice, he may have been aware of current developments in music printing, including the introduction of movable type for musical notation, an innovation from which he would later profit considerably.[4] Wyeth’s printing career led him to the West Indies, then briefly to Philadelphia, and ultimately to Harrisburg, Pennsylvania, where in 1792 he took over the publication of a newspaper which he renamed
Source:
Consumers, compounding pharmacists, physicians practicing bio identical and health freedom advocates are up in arms over this action by Wyeth. States, not the federal government have jurisdiction over compounding pharmacies. Health freedom advocates characterize Wyeth's move as seeking an extension of federal power on its behalf and attempting to eliminate a competitor in a failing market.
Source:
"This award is a testament to these outstanding scientists and their colleagues as well as the pioneering science employed by Wyeth in the development of PREVNAR," says Bernard Poussot, President, Chief Operating Officer and Vice Chairman, Wyeth. "This honor is ... exemplary of the rich talent that is driving leading-edge research at Wyeth that will contribute to the improvement of global public health for years to come."
Source:
MORE ABOUT
Cushing